Matthew O'Brien Joins Piper Jaffray Medical Technology Investment Research Team
December 23 2014 - 2:27PM
Business Wire
Piper Jaffray (NYSE:PJC) is pleased to announce the hiring of
Matthew O’Brien as a principal and senior research analyst. O’Brien
will be based in the firm’s Chicago office, focused on the
orthopaedics and spine space as part of the medical technology
equity research team.
“Piper Jaffray has a longstanding reputation in the medical
technology arena,” said Michael Cox, director of equity research at
Piper Jaffray. “Our medtech leadership reflects an ongoing
commitment to providing relevant and timely insights to clients.
Matt will be integral in contributing to this effort.”
Previously, O’Brien spent 10 years at William Blair &
Company, LLC, where he was most recently a senior analyst leading
coverage of orthopaedics, vision care and heart failure companies.
Prior to that, he worked in investment banking and financial
advisory at Duff & Phelps, LLC. O’Brien holds a bachelor’s
degree in finance from DePaul University and a Master of Business
Administration degree from the University of Chicago.
Piper Jaffray has a total of 29 senior research analysts located
in Minneapolis, New York, San Francisco and Chicago. The firm
provides coverage on approximately 584 companies in the following
key sectors: business & financial services; clean technology
& industrial growth; consumer; healthcare; and technology,
media & telecommunications.
About Piper JaffrayPiper Jaffray Companies (NYSE: PJC) is
an investment bank and asset management firm headquartered in
Minneapolis with offices across the U.S. and in London, Hong Kong*
and Zurich. Securities brokerage and investment banking services
are offered in the United States through Piper Jaffray & Co.,
member NYSE and SIPC, and in Europe through Piper Jaffray Ltd.,
authorized and regulated by the Financial Conduct Authority. Asset
management products and services are offered through three separate
investment advisory affiliates registered with the U.S. Securities
and Exchange Commission: Advisory Research Inc., Piper Jaffray
Investment Management LLC and PJC Capital Partners LLC.
* License pending
Follow Piper Jaffray: LinkedIn | Facebook | Twitter
© 2014 Piper Jaffray Companies, 800 Nicollet Mall, Suite 1000,
Minneapolis, Minnesota 55402-7020
Piper Jaffray & Co.Pamela Steensland,
612-303-8184pamela.k.steensland@pjc.com
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Jul 2023 to Jul 2024